Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to $2.0 million.

  • Ocugen's Share-based Compensation rose 443.97% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 424.86%. This contributed to the annual value of $7.4 million for FY2024, which is 1942.06% down from last year.
  • Per Ocugen's latest filing, its Share-based Compensation stood at $2.0 million for Q3 2025, which was up 443.97% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Ocugen's Share-based Compensation registered a high of $3.3 million during Q1 2022, and its lowest value of $833000.0 during Q1 2021.
  • For the 5-year period, Ocugen's Share-based Compensation averaged around $2.1 million, with its median value being $2.0 million (2025).
  • In the last 5 years, Ocugen's Share-based Compensation surged by 154601.23% in 2021 and then tumbled by 3545.73% in 2023.
  • Over the past 5 years, Ocugen's Share-based Compensation (Quarter) stood at $2.7 million in 2021, then fell by 0.56% to $2.7 million in 2022, then tumbled by 35.46% to $1.7 million in 2023, then increased by 8.94% to $1.9 million in 2024, then grew by 5.33% to $2.0 million in 2025.
  • Its Share-based Compensation was $2.0 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q1 2025.